Efficacy of Treatment for Panic Disorder

This study has been completed.
Sponsor:
Information provided by:
University of British Columbia
ClinicalTrials.gov Identifier:
NCT00456768
First received: April 3, 2007
Last updated: April 28, 2011
Last verified: April 2011

April 3, 2007
April 28, 2011
May 2003
April 2011   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00456768 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Efficacy of Treatment for Panic Disorder
Efficacy of Treatment for Panic Disorder

The purpose of these questionnaires is to give us an overview of how panic has affected your life and perhaps also to give us some clues about things that may have set you up to experience panic.

For us to evaluate the efficacy of our treatment programs, we are interested in your responses before and after treatment. We use two methods to evaluate the efficacy of our treatments: questionnaires and interviews with a member of the Anxiety Disorders Clinic. As part of standard clinic procedure, each person in the program completes an in-person interview with a staff member who will determine your suitability for treatment. If you have received this questionnaire packet, it is likely that your concerns will be appropriately addressed in the Anxiety Disorders Clinic. The purpose of the questionnaire packet is to assess the severity of your panic disorder; its impact on your functioning, and factors that may contribute to the onset or maintenance of your panic (e.g., depression, anxiety sensitivity). We will ask you to complete this questionnaire again when you have completed your treatment along with a brief telephone interview with a staff member of the Anxiety Disorders Clinic.

Observational
Observational Model: Cohort
Not Provided
Not Provided
Probability Sample

Patients referred to the Anxiety Disorders Clinic, Vancouver, who receive a primary diagnosis of Panic Disorder, and are accepted for treatment at the clinic.

Panic Disorder
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
250
April 2011
April 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients referred to the Anxiety Disorders Clinic who receive a primary diagnosis of Panic Disorder, and are accepted for treatment at the clinic.

Exclusion Criteria:

  • Individuals who either have not sought treatment for anxiety at the Anxiety Disorders Clinic or patients who did not receive a primary diagnosis of Panic Disorder.
Both
19 Years to 65 Years
Yes
Contact information is only displayed when the study is recruiting subjects
Canada
 
NCT00456768
H03-80265
No
Dr. Maureen Whittal, University of British Columbia
University of British Columbia
Not Provided
Principal Investigator: Maureen Whittal, Ph.D University of British Columbia
University of British Columbia
April 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP